Examkin

Question

Difficulty: Very hardPulmonary and Critical Care

A 37-year-old woman presents to the clinic with an 8-month history of progressive shortness of breath. She reports initially feeling winded only during heavy exertion, but her dyspnea now occurs when walking short distances on flat ground. Last week, she experienced a syncopal episode while climbing stairs. She has no significant past medical history, takes no medications, and has never smoked. Vital signs show temperature 37.0°C (98.6°F), blood pressure 110/72 mm Hg, pulse 94/min, and respirations 18/min. Oxygen saturation is 96% on room air. Physical examination reveals clear breath sounds bilaterally. Cardiovascular examination is notable for a palpable left parasternal heave and a prominently accentuated pulmonic component of the second heart sound (P2). Jugular venous pressure is estimated at 9 cm H2O. There is trace bilateral lower extremity edema.

Arrange the following diagnostic steps in the most appropriate sequential order for evaluating this patient's condition, starting from the initial evaluation step to the final confirmatory assessment.

  1. 1Perform transthoracic echocardiography
  2. 2Obtain pulmonary function testing and high-resolution computed tomography of the chest
  3. 3Perform a ventilation/perfusion (V/Q) scan
  4. 4Perform right heart catheterization
  5. 5Conduct vasoreactivity testing with inhaled nitric oxide

Answer

The correct sequence for the diagnostic evaluation of unexplained pulmonary hypertension begins with transthoracic echocardiography, followed by pulmonary function testing and high-resolution CT, then a ventilation/perfusion (V/Q) scan, followed by right heart catheterization, and concluding with vasoreactivity testing.
The evaluation of suspected pulmonary hypertension follows a strict stepwise algorithm designed to rule out common secondary causes before resorting to invasive procedures. Transthoracic echocardiography is always the initial screening test. Once elevated pulmonary pressures are suspected, the patient must be evaluated for left heart disease (Group 2), lung disease (Group 3 via PFTs and HRCT), and chronic thromboembolic disease (Group 4 via V/Q scan). Only when these secondary causes are excluded does the patient undergo right heart catheterization to invasively confirm Group 1 Pulmonary Arterial Hypertension. Vasoreactivity testing is the final step, conducted during the catheterization, to guide targeted medical therapy.

Step-by-Step Solution

1
Perform transthoracic echocardiography
Estimates pulmonary pressures and rules out left heart disease.
Echocardiography is the most appropriate initial screening tool for suspected pulmonary hypertension and effectively evaluates for Group 2 pulmonary hypertension (left heart disease), the most common overall cause.
2
Obtain pulmonary function testing and high-resolution computed tomography of the chest
Evaluates for interstitial, restrictive, or obstructive lung pathology.
If left heart disease is absent, Group 3 pulmonary hypertension (lung disease/hypoxia) must be evaluated next using comprehensive pulmonary imaging and functional testing.
3
Perform a ventilation/perfusion (V/Q) scan
Screens for chronic thromboembolic pulmonary hypertension (CTEPH).
V/Q scanning is highly sensitive for chronic thromboemboli and is favored over CT pulmonary angiography in the chronic outpatient workup to rule out Group 4 pulmonary hypertension.
4
Perform right heart catheterization
Confirms mean pulmonary arterial pressure and pulmonary capillary wedge pressure.
Invasive hemodynamic measurement is mandatory to definitively diagnose Group 1 Pulmonary Arterial Hypertension (PAH) once secondary causes (Groups 2, 3, and 4) have been noninvasively excluded.
5
Conduct vasoreactivity testing with inhaled nitric oxide
Identifies patients who have a significant drop in mean pulmonary arterial pressure.
This is performed concurrently with the right heart catheterization in Group 1 PAH patients to identify a small subset who will respond to targeted calcium channel blocker therapy.

Key Concept

Algorithmic approach to the diagnosis of Pulmonary Hypertension (PH)
Rate this question

Topics

Pulmonary and Critical Care

More questions from this topic